Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy

The results of using a standard combination of cytotoxic agents in 27 cases of secondary liver cancer are reported. A brief review of the methods available for treating hepatic metastases from solid tumours, as opposed to lymphomata, is included. The response rate depends on the site of the primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Priestman, T. J., Hanham, I. W. F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1972
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008661/
https://www.ncbi.nlm.nih.gov/pubmed/4647397
_version_ 1782135961193283584
author Priestman, T. J.
Hanham, I. W. F.
author_facet Priestman, T. J.
Hanham, I. W. F.
author_sort Priestman, T. J.
collection PubMed
description The results of using a standard combination of cytotoxic agents in 27 cases of secondary liver cancer are reported. A brief review of the methods available for treating hepatic metastases from solid tumours, as opposed to lymphomata, is included. The response rate depends on the site of the primary lesion. It is suggested that in patients with mammary or colorectal primary tumours, combination chemotherapy represents an advance in treatment with an objective response rate of 73% and 66% respectively in the 2 groups. The method requires no specialized equipment as neither grossly deranged liver enzymes nor jaundice are contra-indications to treatment, and toxicity is easily monitored and readily controlled. IMAGES:
format Text
id pubmed-2008661
institution National Center for Biotechnology Information
language English
publishDate 1972
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20086612009-09-10 Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy Priestman, T. J. Hanham, I. W. F. Br J Cancer Articles The results of using a standard combination of cytotoxic agents in 27 cases of secondary liver cancer are reported. A brief review of the methods available for treating hepatic metastases from solid tumours, as opposed to lymphomata, is included. The response rate depends on the site of the primary lesion. It is suggested that in patients with mammary or colorectal primary tumours, combination chemotherapy represents an advance in treatment with an objective response rate of 73% and 66% respectively in the 2 groups. The method requires no specialized equipment as neither grossly deranged liver enzymes nor jaundice are contra-indications to treatment, and toxicity is easily monitored and readily controlled. IMAGES: Nature Publishing Group 1972-12 /pmc/articles/PMC2008661/ /pubmed/4647397 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Priestman, T. J.
Hanham, I. W. F.
Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title_full Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title_fullStr Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title_full_unstemmed Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title_short Results of 27 Cases with Hepatic Metastases Treated by Combination Chemotherapy
title_sort results of 27 cases with hepatic metastases treated by combination chemotherapy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2008661/
https://www.ncbi.nlm.nih.gov/pubmed/4647397
work_keys_str_mv AT priestmantj resultsof27caseswithhepaticmetastasestreatedbycombinationchemotherapy
AT hanhamiwf resultsof27caseswithhepaticmetastasestreatedbycombinationchemotherapy

Ejemplares similares